Silo Pharma, Inc.
SILO · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Weisblum Eric: Form 4
Insider disclosure · Filed · Report period 15 Dec 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001514183 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SILO on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 677 N. Washington Blvd, Sarasota, FL, 34236
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- Uppercut Brands, Inc. (to 14 Aug 2020), Point Capital, Inc. (to 14 May 2019), Gold Swap Inc (to 07 Jan 2013)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields